|
A (b)(6) result was reported on a plasma sample tested with the alere determine hiv 1/2 ag/ab combo.The patient was confirmed (b)(6) test.There is insufficient information to determine if a malfunction occurred.The patient gender, pregnancy status, treatment and patient outcome were unknown.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by alere (b)(4), inc.; however, this mdr is a retrospective filing in response to an observation from an fda inspection conducted (b)(4) to (b)(4) 2018 at alere (b)(4), inc.((b)(4)).
|